“Oppenheimer: These 2 Stocks Are Poised to Surge by Over 100%”
September 30, 2020
“Brickell Biotech (BBI)…
Looking at the consensus breakdown, 2 Buys and no Holds or Sells have been published in the last three months. As a result, BBI gets a Moderate Buy consensus rating. The $5 average price target is identical to Gershell’s….
Aldeyra Therapeutics (ALDX)…
What does the rest of the Street have to say? Only Buy ratings, 2 to be exact, have been issued in the last three months. So, the consensus rating is a Moderate Buy. In addition, the $23.50 average price target suggests 227% upside potential from current levels…”
https://finance.yahoo.com/news/oppenheimer-2-stocks-poised-surge-143051046.html